Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Specify a stock or a cryptocurrency in the search bar to get a summary
Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
DexCom Inc
DC4Current price
62.93 EUR
+1.05 EUR (+1.70%)
Last closed
63.38 EUR
Company
–
ISIN
US2521311074
Sector
Healthcare
Industry
Medical Devices
Exchange
Frankfurt Exchange
Capitalization
25 143 364 948 EUR
Yield for 12 month
-28.12 %
1Y
3Y
5Y
10Y
15Y
DC4
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include Dexcom G6 and Dexcom G7, integrated CGM systems for diabetes management; Dexcom Share, a remote monitoring system; Dexcom Real-Time API, which enables authorized third-party software developers to integrate real-time CGM data into their digital health apps and devices; and Dexcom ONE, that is designed to replace finger stick blood glucose testing for diabetes treatment decisions. It has also submitted FDA review for Dexcom Stelo for people with type 2 diabetes. The company has a collaboration and license agreement with Verily Life Sciences LLC and Verily Ireland Limited to develop blood-based or interstitial glucose monitoring products. It markets its products directly to endocrinologists, physicians, and diabetes educators. The company was incorporated in 1999 and is headquartered in San Diego, California. Address: 6340 Sequence Drive, San Diego, CA, United States, 92121
Check your investment idea
Find the best to beat the market
TSLA
Tesla Motors
AAPL
Apple
MSFT
Microsoft
Analytics
WallStreet Target Price
476.92 EURP/E ratio
42.6759Dividend Yield
–Current Year
+3 622 126 717 EUR
Last Year
+2 909 660 802 EUR
Current Quarter
+1 004 251 957 EUR
Last Quarter
+920 955 942 EUR
Current Year
+2 288 790 504 EUR
Last Year
+1 883 009 916 EUR
Current Quarter
+626 670 020 EUR
Last Quarter
+561 873 120 EUR
Key Figures DC4
1 year
3 years
5 years
10 years
EBITDA
886 757 577 EUR
Operating Margin TTM
PE Ratio
42.6759
Return On Assets TTM
6.26 %
PEG Ratio
1.0582
Return On Equity TTM
29.41 %
Wall Street Target Price
476.92 EUR
Revenue TTM
3 934 611 640 EUR
Book Value
6.07 EUR
Revenue Per Share TTM
Dividend Share
–
Quarterly Revenue Growth YOY
15.3 %
Dividend Yield
–
Gross Profit TTM
1 883 009 917 EUR
Earnings per share
1.45 EUR
Diluted Eps TTM
1.45 EUR
Most Recent Quarter
II 2024
Quarterly Earnings Growth YOY
26.6 %
Profit Margin
16.95 %
Dividend Analytics DC4
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History DC4
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
–
Ex Dividend Date
–
Forward Annual Dividend Yield
–
Last Split Factor
4:1
Payout Ratio
–
Last Split Date
13.06.2022
Dividend Date
–
Stock Valuation DC4
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
42.6759
Forward PE
33.0033
Enterprise Value Revenue
6.9452
Price Sales TTM
6.3903
Enterprise Value EBITDA
26.4961
Price Book MRQ
11.2844
Financials DC4
1 year
3 years
5 years
10 years
15 years
| Results | 2019 | Dynamics |
* The data for this period has not yet been published
Technical indicators DC4
For 52 weeks
56.8 EUR
131.87 EUR
50 Day MA
75.17 EUR
Shares Short Prior Month
–
200 Day MA
105.14 EUR
Short Ratio
–
Shares Short
–
Short Percent
–
BeatStart